LINC01924

Across TCGA pan-cancer cohorts, LINC01924 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of LINC01924’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01924 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01924 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.

KIRC, BRCA, and KIRP are the cancer types where LINC01924 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01924 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	II,III,IV	−0.457	<.001	11	view →
BRCA	All	II,III,IV	+0.214	<.001	6	view →
KIRP	Male	All	−0.133	.001	4	view →
LUAD	All	All	+0.143	.006	2	view →
HNSC	Male	All	+0.012	.043	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

LINC01924–KIRC

Open the KIRC breakdown →